- Home
- PNNT vs KMDA Comparison
PNNT vs KMDA Comparison
Compare PNNT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- KMDA
- Stock Information
- Founded
- PNNT 2007
- KMDA 1990
- Country
- PNNT United States
- KMDA Israel
- Employees
- PNNT N/A
- KMDA N/A
- Industry
- PNNT Finance: Consumer Services
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- PNNT Finance
- KMDA Health Care
- Exchange
- PNNT Nasdaq
- KMDA Nasdaq
- Market Cap
- PNNT 442.7M
- KMDA 399.7M
- IPO Year
- PNNT 2007
- KMDA N/A
- Fundamental
- Price
- PNNT $6.92
- KMDA $7.88
- Analyst Decision
- PNNT Sell
- KMDA Strong Buy
- Analyst Count
- PNNT 3
- KMDA 3
- Target Price
- PNNT $5.88
- KMDA $14.67
- AVG Volume (30 Days)
- PNNT 339.0K
- KMDA 83.3K
- Earning Date
- PNNT 08-06-2025
- KMDA 08-13-2025
- Dividend Yield
- PNNT 13.75%
- KMDA 2.54%
- EPS Growth
- PNNT N/A
- KMDA 31.21
- EPS
- PNNT 0.73
- KMDA 0.28
- Revenue
- PNNT $138,371,000.00
- KMDA $167,235,000.00
- Revenue This Year
- PNNT N/A
- KMDA $14.51
- Revenue Next Year
- PNNT N/A
- KMDA $9.31
- P/E Ratio
- PNNT $9.56
- KMDA $27.89
- Revenue Growth
- PNNT N/A
- KMDA 11.83
- 52 Week Low
- PNNT $5.72
- KMDA $5.08
- 52 Week High
- PNNT $8.04
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- PNNT 62.95
- KMDA 69.92
- Support Level
- PNNT $6.59
- KMDA $7.61
- Resistance Level
- PNNT $6.78
- KMDA $7.86
- Average True Range (ATR)
- PNNT 0.11
- KMDA 0.20
- MACD
- PNNT 0.02
- KMDA 0.04
- Stochastic Oscillator
- PNNT 100.00
- KMDA 77.46
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.